ICER’s Positive Cost-Effectiveness Assessment Lends Support For New Sickle Cell Disease Gene Therapies Read more
When Launched, Gene Therapy Roctavian Will Be Administered Mainly In 340B-Eligible Treatment Centers, Where It Will Be Substantially Discounted In Price Read more
Biotech Leader Shares How Rocket Pharmaceuticals Is Working To Eradicate Rare Diseases In Children Read more